Centiva Capital’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,801
Closed -$285K 1984
2023
Q2
$285K Sell
4,801
-521
-10% -$31.2K 0.01% 1147
2023
Q1
$333K Buy
5,322
+1,148
+28% +$71.7K 0.01% 1009
2022
Q4
$261K Buy
4,174
+167
+4% +$9.58K 0.01% 1012
2022
Q3
$200K Buy
+4,007
New +$222K ﹤0.01% 1178
2021
Q4
Sell
-3,852
Closed -$216K 1460
2021
Q3
$216K Buy
+3,852
New +$212K 0.01% 905

Other funds holding PBH

Centiva Capital's PBH Position: Q3 2023 in Review

Centiva Capital sold out of Prestige Consumer Healthcare (PBH) in Q3 2023, closing a stake of 4,801 shares — an estimated $285K sold.

Centiva Capital first reported a position in PBH in Q3 2021 and held it in 5 quarters. The position peaked at $333K in Q1 2023. 278 funds tracked by Wall St. Rank hold PBH as of Q3 2023.

  • Centiva Capital reported no remaining Prestige Consumer Healthcare position as of Q3 2023 after selling out during the quarter.
  • Centiva Capital sold 4,801 Prestige Consumer Healthcare shares in Q3 2023, an estimated $285K.
  • Centiva Capital first reported a position in Prestige Consumer Healthcare in Q3 2021 and held it in 5 quarters.
  • Centiva Capital's Prestige Consumer Healthcare position peaked at $333K in Q1 2023.
  • 278 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2023.

Based on Centiva Capital's 13F filing for Q3 2023, filed 14 Nov 2023.